← Back to catalogue

501041

EUDAMEDFDA UDI

Class I (EU MDR)

Ref 501041Model Eye Shield

by Surgistar Inc.

Identity

Trade Name
SURGISTAR FDA UDI
Generic Name
Surgical eye pressure shield FDA UDI
Model / Reference
Eye Shield EUDAMED
501041 EUDAMEDFDA UDI

Identifiers

Primary DI / UDI-DI
00878799008091 EUDAMEDFDA UDI
Basic UDI-DI
087879900EYESHIELD6L EUDAMED
FDA Product Code
HOY FDA UDI
EMDN Code
Q029001 RIGID MONOCULAR MASKS EUDAMED
GMDN Term
Surgical eye pressure shield FDA UDI

Classification

Device Class
Class I EUDAMEDFDA UDI
Regulation Number
886.4750 FDA UDI
Market of Registration
Northern Ireland EUDAMED
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

EUDAMEDFDA UDI

Single Use

No

FDA UDI

Implantable

No

EUDAMEDFDA UDI

Reusable

No

EUDAMED

Contains Latex

No

EUDAMEDFDA UDI

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

501041 by Surgistar Inc. — Class I — MDR, FDA UDI — listed in EUDAMED, FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

CE/MDR

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Surgistar Inc.
EUDAMED SRN
US-MF-000003747
Authorised Representative
Wellkang Ltd XI-AR-000001836

Sources (2)

  • EUDAMED 414f730c-d7d0-4658-b88c-408d558099b1 61 fields · synced Jul 20, 2026
  • FDA UDI 7f728a10-1be1-4e91-bf05-eac186d5be01 33 fields · synced May 30, 2026